ALLR
ALLR
NASDAQ · Biotechnology

Allarity Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.83
+0.02 (+2.56%)
As of Feb 8, 2:27 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +3,822.0% upside
Low Target $17.80
Average Target $32.58
High Target $40.39
Current Price $0.83
Current
$0.83
Target
$32.58
$17.80 $32.58 avg $40.39
Scenario Analysis
Bear Case
$17.80
2,042.8%
Low target
Base Case
$32.58
+3,822.0%
Avg target
Bull Case
$40.39
+4,762.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$25.81
-96.8% from high
52-Week Low
$19.95
+-95.8% from low
Target vs 52W High
$32.58
+26.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
 Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
 Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
 Hold 42 48% $91.45 -54.5%